PharmaTech Integrates 2023
CPI's Medicines Manufacturing Innovation Centre (MMIC) and the National Manufacturing Institute Scotland (NMIS), 21 September 2023, GLASGOW
KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS
Tours available from our sponsors on 20th September in CMAC and on 21st September in MMIC and NMIS. Please follow individual links for further information.
DIGITAL AND DATA
Defining and implementing the right digital and data strategies for Pharma’s future
THERAPIES
Focusing on new therapies and the technology developments required for them to realise their full potential
MANUFACTURE AND FORMULATION
Focusing on advances in manufacturing, formulation and drug delivery technologies
Registration and Networking
08:20 – 09:00
Registration and Networking
Welcome & Opening Remarks
09:05 – 09:15
Welcome & Opening Remarks
Dave Tudor | Managing Director, Medicines Manufacturing Innovation Centre, Biologics & Quality | CPI
Fireside Chat 1
09:15 – 09:50
Fireside Chat 1: Future Industry Challenges
– What are the future challenges facing the Pharma industry?
– What role will Digital Innovation play?
Speakers include:
Ian McCubbin | Chair | RoslinCT | Chair | Cell and Gene Therapy Catapult
Ian Rees | Regulatory Affairs Consultant | DI REES Ltd
David Littlejohn | Special Advisor to the Principal | University of Strathclyde
Interviewed by:
Maureen Wedderburn | Non Executive Chair, Medicines Manufacturing Innovation Centre | CPI
Session 1
10:00 – 10:50
Digital Integration and Differentiation – you do the maths!
How to effectively deliver integrated digital and data infrastructure and what difference that will make to advance pharmaceutical manufacturing, quality and compliance.
Oligo-new-cleotides
Addressing the unique analytical, manufacture and regulatory challenges for Oligonucleotides
Please join Track 1 or 2
Networking
10:50 – 11:30
Networking coffee break
Session 2
11:30 – 12:20
Standardly unstandardised
Why is standardisation important, what are the barriers and why are memberships important to reduce the barrier?
Please join Track 1 or 3
This is intense
It costs too much and it takes too long? How do we intensify processess and turbocharge productivity?
Session 3
12:30 – 13:20
Please join Track 2 or 3
Towards digital transformation of Chemistry, Manufacturing and Controls (CMC): Academic and Industry Perspectives
Joint presentation with both Ivan Marziano and Alastair Florence.
Manufacturing as a key to achieving Net Zero
Many companies have signed up to Net Zero. With a significant proportion of emissions associated with the design of medicines and processes – what does manufacturing need to deliver to achieve net zero and how can Manufacturing Technologies deliver a Sustainability future?
Networking
13:20 – 14:20
Networking lunch break
Session 4
14:20 – 15:10
Supply Chain Reaction
The Pharma and Life Sciences sector is undergoing unprecedented change. Artificial Intelligence (AI) and Machine Learning operations have become progressive disruptors, being enabled by data as a catalyst. The operations landscape converges towards a highly integrated End-to-End value chain. Accordingly modularity, digital elevation, resilience and sustainability emerge as new ‘by-design’ criteria.
Please join Track 1 or 3
Uncertainty is certain!
Managing manufacturing and supply chains for unpredictable demand. What’s the reality in delivering agility?
Fireside Chat 2
15:20 – 15:55
Fireside Chat 2: Transforming Drug Development
– Exploring Breakthrough Digital Technologies and System Thinking Approaches to Revolutionise Manufacturing and Supply
Speakers include:
Rebecca Vangenechten | Head Vertical Pharma Segment | Siemens
Chris Kopinski | Head of Strategy & Business Development HCLS/Manufacturing Industry Products | Amazon Web Services (AWS)
Paul Hardy | Client Executive Partner | Atos
Interviewed by:
Dave Tudor | Managing Director, Medicines Manufacturing Innovation Centre, Biologics & Quality | CPI
Drinks Reception
15:55 – 16:55
Networking drinks reception
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.
PharmaTech Integrates 2023
CPI's Medicines Manufacturing Innovation Centre (MMIC) and the National Manufacturing Institute Scotland (NMIS), 21 September 2023, GLASGOW
KEYNOTES, FIRESIDE CHATS AND PANEL DISCUSSIONS
Tours available from our sponsors on 20th September in CMAC and on 21st September in MMIC and NMIS. Please follow individual links for further information.
Registration and Networking
08:20 – 09:00
Welcome & Opening Remarks
09:05 – 09:15
Dave Tudor | Managing Director, Medicines Manufacturing Innovation Centre, Biologics & Quality | CPI
Fireside Chat 1
09:15 – 09:50
Fireside Chat 1: Future Industry Challenges
– What are the future challenges facing the Pharma industry?
– What role will Digital Innovation play?
Speakers include:
Ian McCubbin | Chair | RoslinCT
Ian Rees | Regulatory Affairs Consultant | DI REES Ltd
David Littlejohn | Special Advisor to the Principal | University of Strathclyde
Interviewed by:
Maureen Wedderburn | Non Executive Chair, Medicines Manufacturing Innovation Centre | CPI
DIGITAL AND DATA
Defining and implementing the right digital and data strategies for Pharma’s future
Session 1
10:00 – 10:50
Digital Integration and Differentiation – you do the maths!
How to effectively deliver integrated digital and data infrastructure and what difference that will make to advance pharmaceutical manufacturing, quality and compliance.
Coffee break & Networking
10:50 – 11:30
Session 2
11:30 – 12:20
Standardly unstandardised
Why is standardisation important, what are the barriers and why are memberships important to reduce the barrier?
Session 3
12:30 – 13:20
Please join track 2 or 3.
Lunch break & Networking
13:20 – 14:20
Session 4
14:20 – 15:10
Supply Chain Reaction
The Pharma and Life Sciences sector is undergoing unprecedented change. Artificial Intelligence (AI) and Machine Learning operations have become progressive disruptors, being enabled by data as a catalyst. The operations landscape converges towards a highly integrated End-to-End value chain. Accordingly modularity, digital elevation, resilience and sustainability emerge as new ‘by-design’ criteria.
Fireside Chat 2
15:20 – 15:55
Transforming Drug Development
– Exploring Breakthrough Digital Technologies and System Thinking Approaches to Revolutionise Manufacturing and Supply
Speakers include:
Rebecca Vangenechten | Head Vertical Pharma Segment | Siemens
Chris Kopinski | Head of Strategy & Business Development HCLS/Manufacturing Industry Products | Amazon Web Services (AWS)
Paul Hardy | Client Executive Partner | Atos
Richard Milne | Vice President & General Manager, Digital Science Solutions, Thermo Fisher Scientific
Interviewed by:
Dave Tudor | Managing Director, Medicines Manufacturing Innovation Centre, Biologics & Quality | CPI
Drinks Reception
15:55 – 16:55
THERAPIES
Focusing on new therapies and the technology developments required for them to realise their full potential
Session 1
10:00 – 10:50
Oligo-new-cleotides
Addressing the unique analytical, manufacture and regulatory challenges for Oligonucleotides
Coffee break & Networking
10:50 – 11:30
Session 2
11:30 – 12:20
Please join track 1 or 3.
Session 3
12:30 – 13:20
Towards digital transformation of Chemistry, Manufacturing and Controls (CMC): Academic and Industry Perspectives
Joint presentation with both Ivan Marziano and Alastair Florence.
Lunch break & Networking
13:20 – 14:20
Session 4
14:20 – 15:10
Please join track 1 or 3.
Fireside Chat 2
15:20 – 15:55
Transforming Drug Development
– Exploring Breakthrough Digital Technologies and System Thinking Approaches to Revolutionise Manufacturing and Supply
Speakers include:
Rebecca Vangenechten | Head Vertical Pharma Segment | Siemens
Chris Kopinski | Head of Strategy & Business Development HCLS/Manufacturing Industry Products | Amazon Web Services (AWS)
Paul Hardy | Client Executive Partner | Atos
Richard Milne | Vice President & General Manager, Digital Science Solutions, Thermo Fisher Scientific
Interviewed by:
Dave Tudor | Managing Director, Medicines Manufacturing Innovation Centre, Biologics & Quality | CPI
Drinks Reception
15:55 – 16:55
MANUFACTURE AND FORMULATION
Focusing on advances in manufacturing, formulation and drug delivery technologies
Session 1
10:00 – 10:50
Please join track 1 or 2.
Coffee break & Networking
10:50 – 11:30
Session 2
11:30 – 12:20
This is intense
The industry has a well established batch-based supply chain, often based around multipurpose plant. These offer product flexibility, and scale-up from development into manufacturing is well understood. However, scale-up often compromises the optimum process conditions, resulting in less resource efficient processes and increased cost. The “make to stock” business model these facilities dictate can adversely impact response to changes in demand. As governments seek to build resilience in the medicines supply chain post pandemic, and the industry seeks to reach net zero, the time may have come for more widespread uptake of process intensification. This panel will explore the strengths, weaknesses, opportunities and threats of these technologies.
Session 3
12:30 – 13:20
Manufacturing as a key to achieving Net Zero
Many companies have signed up to Net Zero. With a significant proportion of emissions associated with the design of medicines and processes – what does manufacturing need to deliver to achieve net zero and how can Manufacturing Technologies deliver a Sustainability future?
Lunch break & Networking
13:20 – 14:20
Session 4
14:20 – 15:10
Uncertainty is certain!
Managing manufacturing and supply chains for unpredictable demand. What’s the reality in delivering agility?
Fireside Chat 2
15:20 – 15:55
Transforming Drug Development
– Exploring Breakthrough Digital Technologies and System Thinking Approaches to Revolutionise Manufacturing and Supply
Speakers include:
Rebecca Vangenechten | Head Vertical Pharma Segment | Siemens
Chris Kopinski | Head of Strategy & Business Development HCLS/Manufacturing Industry Products | Amazon Web Services (AWS)
Paul Hardy | Client Executive Partner | Atos
Richard Milne | Vice President & General Manager, Digital Science Solutions, Thermo Fisher Scientific
Interviewed by:
Dave Tudor | Managing Director, Medicines Manufacturing Innovation Centre, Biologics & Quality | CPI
Drinks Reception
15:55 – 16:55
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.